Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72960-1

By:

• Kappes, Lucy;
• Amer, Ruba L.;
• Sommerlatte, Sabine;
• Bashir, Ghada;
• Plattfaut, Corinna;
• Gieseler, Frank;
• Gemoll, Timo;
• Busch, Hauke;
• Altahrawi, Abeer;
• Al-Sbiei, Ashraf;
• Haneefa, Shoja M.;
• Arafat, Kholoud;
• Schimke, Lena F.;
• Khawanky, Nadia El;
• Schulze-Forster, Kai;
• Heidecke, Harald;
• Kerstein-Staehle, Anja;
• Marschner, Gabriele;
• Pitann, Silke;
• Ochs, Hans D.

Publication type:

Article